Given that RelAT505A MEFs displayed resistance to CHK1i treatment (Figure 2B, Supplementary Figure S2A,B), we hypothesised that Eμ-Myc/RelaT505A tumours would also show altered sensitivity to CHK1 inhibition in vivo. This evidence concerns the gene CHEK1 and neoplasm.